| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.4 | 0.04 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |